These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10943240)

  • 21. [Pyoderma gangrenosum--a less well known ulcerous skin disease].
    Kostiainen M; Snellman E; Vaalasti A; Rantanen T; Reunala T
    Duodecim; 2002; 118(10):1033-7. PubMed ID: 12237998
    [No Abstract]   [Full Text] [Related]  

  • 22. Pyoderma gangrenosum of the penis.
    Farrell AM; Black MM; Bracka A; Bunker CB
    Br J Dermatol; 1998 Feb; 138(2):337-40. PubMed ID: 9602887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical tacrolimus (FK506) in the treatment of recalcitrant parastomal pyoderma gangrenosum associated with Crohn's disease: report of two cases.
    Khurrum Baig M; Marquez H; Nogueras JJ; Weiss EG; Wexner SD
    Colorectal Dis; 2004 Jul; 6(4):250-3. PubMed ID: 15206967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of recalcitrant pyoderma gangrenosum with infliximab complicated by tuberculosis despite negative screening tests.
    Uthman I; El-Sayad J; Sharara A
    Clin Exp Dermatol; 2005 May; 30(3):294. PubMed ID: 15807693
    [No Abstract]   [Full Text] [Related]  

  • 25. Pyoderma gangrenosum in an infant.
    Torrelo A; Colmenero I; Serrano C; Vilanova A; Naranjo R; Zambrano A
    Pediatr Dermatol; 2006; 23(4):338-41. PubMed ID: 16918628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyoderma gangrenosum as initial manifestation of Graves' disease.
    Livideanu C; Lipsker D; Paul C; Juillard J; Schubert B
    Clin Exp Dermatol; 2006 Sep; 31(5):659-61. PubMed ID: 16780496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic pyoderma gangrenosum responding to infliximab and adalimumab.
    Hubbard VG; Friedmann AC; Goldsmith P
    Br J Dermatol; 2005 May; 152(5):1059-61. PubMed ID: 15888172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Infliximab for the management of pyoderma gangrenosum in inflammatory bowel disease: one for all?].
    Tanczos BT; Baumgart DC
    Z Gastroenterol; 2006 Jul; 44(7):609-10. PubMed ID: 16823703
    [No Abstract]   [Full Text] [Related]  

  • 29. Pathergic pyoderma gangrenosum in a venous ulcer.
    Rosina P; Cunego S; Franz CZ; D'Onghia FS; Chieregato G
    Int J Dermatol; 2002 Mar; 41(3):166-7. PubMed ID: 12010342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyoderma gangrenosum successfully treated with cyclosporin A.
    V'lckova-Laskoska MT; Laskoski DS; Caca-Biljanovska NG; Darkoska JS
    Adv Exp Med Biol; 1999; 455():541-5. PubMed ID: 10599396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab.
    López San Román A; Bermejo F; Aldanondo I; Carrera E; Boixeda D; Muñoz Zato E
    Rev Esp Enferm Dig; 2004 Jun; 96(6):420-2; 422-4. PubMed ID: 15230672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thalidomide and its dermatologic uses.
    Paghdal KV; Schwartz R
    Acta Dermatovenerol Croat; 2007; 15(1):39-44. PubMed ID: 17433179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody.
    Tan MH; Gordon M; Lebwohl O; George J; Lebwohl MG
    Arch Dermatol; 2001 Jul; 137(7):930-3. PubMed ID: 11453813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scrotal pyoderma gangrenosum associated with dermatomyositis.
    Shah M; Lewis FM; Harrington CI
    Clin Exp Dermatol; 1996 Mar; 21(2):151-3. PubMed ID: 8759207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pyoderma gangrenosum. 15 cases].
    Riahi I; Mokni M; Haouet S; Cherif F; El Euch D; Azaiz MI; Zitouna MM; Ben Osman-Dhahri A
    Ann Med Interne (Paris); 2001 Feb; 152(1):3-9. PubMed ID: 11240419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of Pyoderma gangrenosum with potassium iodide.
    Asahina A; Minatani Y; Tada Y; Mitsui H; Tamaki K
    Acta Derm Venereol; 2006; 86(1):84-5. PubMed ID: 16586005
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pyoderma gangrenosum--positive effect of cyclosporin A therapy ].
    Krauze E; Lis A; Kamińska-Budzińska G; Wygledowska-Kania M; Pierzchała E; Brzezińska-Wcisło L
    Pol Merkur Lekarski; 2002 Oct; 13(76):336-40. PubMed ID: 12557445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pyoderma gangrenosum and orbital pseudotumor].
    Welzel C; Bloching M; Born S; Berghaus A
    HNO; 2003 Jun; 51(6):486-91. PubMed ID: 12858856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapy Insight: pyoderma gangrenosum-old disease, new management.
    Campbell S; Cripps S; Jewell DP
    Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):587-94. PubMed ID: 16327838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pyoderma gangrenosum with an atypical location and a rapid response to cyclosporin A].
    Ferrer Ríos T; Ramos Lora M; Pallarés Manrique H; Pérez Gómez MB; Garrido Mora M; Carrasco FJ; Domínguez Macías A
    Gastroenterol Hepatol; 1999 May; 22(5):227-9. PubMed ID: 10396103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.